Skip to main content

Advertisement

Table 5 PCDHAC2, PCDHGC5 and PCDH10 methylation status according to clinicopathological features of patients (n = 23)

From: High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma

Sample ID Age range (yr) Tumor stage Methylation status (%)
PCDHAC2 PCDHGC5 PCDH10
PKCH2207 T 65–70   0 100 0
PKCH2007 T 60–65 II 0 100 0
PKCH2807 T 55–60 III 0 100 0
PKCH2908 T 75–80 III 0 100 0
PKCH3708 T 45–50 III 0 100 0
PKCH3808 T 75–80 III 0 100 0
PKCH12411 T 55–60   0 100 50
PKCH13311 T 65–70 III 0 100 50
PKCH2607 T 75–80 II 0 100 50
PKCH2507 T 70–75 III 0 100 50
PKCH3408 T 75–80 III 0 100 55
PKCH21913 T 60–65 III    0
PKCH5309 T 50–55 II    0
PKCH20212 T 55–60 III    0
PKCH17112 T 70–75 III    8
PKCH14511 T 50–55 III    9
PKCH20712 T 70–75 II    9
PKCH17612 T 55–60 III    65
PKCH14111 T 65–70 II    80
PKCH10410 T 70–75 III    83
PKCH8510 T 45–50 III    80
PKCH9610 T 70–75 III    90
PKCH15511 T 35–40 II    91